Vanderbilt University signed an option and limited license agreement with KIYATEC, a company dedicated to commercializing 3D cell culture technologies.
A good opportunity for new ventures in the life sciences industry opened today. The second annualLife Science Tennessee Venture Forumis now accepting applications for the 2013 competition.
DiaTech Oncology, a Brentwood-based clinical pathology lab that licensed technology from Vanderbilt in 2009, is popping up in local and national publications after announcing it has secured $18 million in venture financing from investors.
